Found: 134
Select item for more details and to access through your institution.
Osteonecrosis in human immunodeficiency virus (HIV)-infected patients: a multicentric case-control study.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Comment on: Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.
- Published in:
- 2020
- By:
- Publication type:
- letter
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 9, p. 2163, doi. 10.1093/jac/dkae190
- By:
- Publication type:
- Article
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned?
- Published in:
- Healthcare (2227-9032), 2024, v. 12, n. 4, p. 417, doi. 10.3390/healthcare12040417
- By:
- Publication type:
- Article
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients.
- Published in:
- Journal of the International Association of Providers of AIDS Care, 2019, v. 18, p. 1, doi. 10.1177/2325958218821657
- By:
- Publication type:
- Article
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.847816
- By:
- Publication type:
- Article
Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS.
- Published in:
- Patient Preference & Adherence, 2015, v. 9, p. 1213, doi. 10.2147/PPA.S88490
- By:
- Publication type:
- Article
Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: Neglected no more?
- Published in:
- PLoS Neglected Tropical Diseases, 2017, v. 11, n. 3, p. 1, doi. 10.1371/journal.pntd.0005237
- By:
- Publication type:
- Article
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192627
- By:
- Publication type:
- Article
HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0190302
- By:
- Publication type:
- Article
Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0189425
- By:
- Publication type:
- Article
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial.
- Published in:
- PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0187393
- By:
- Publication type:
- Article
Continuum of care for children and adolescents within a European setting: a patient-centred approach.
- Published in:
- HIV Nursing, 2017, v. 17, n. 1, p. 31
- By:
- Publication type:
- Article
Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients.
- Published in:
- Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2012, v. 18, n. 4, p. 587, doi. 10.1007/s10156-012-0402-y
- By:
- Publication type:
- Article
Effectiveness of a Counseling Intervention to Increase Vaccination Uptake among Men Who Have Sex with Men during the Mpox Outbreak.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 751, doi. 10.3390/vaccines12070751
- By:
- Publication type:
- Article
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression.
- Published in:
- Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071141
- By:
- Publication type:
- Article
Influence of efavirenz and 8‐hydroxy‐efavirenz plasma levels on cognition and central nervous system side effects.
- Published in:
- HIV Medicine, 2024, v. 25, n. 4, p. 491, doi. 10.1111/hiv.13600
- By:
- Publication type:
- Article
Trend over time of HIV‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA).
- Published in:
- HIV Medicine, 2023, v. 24, n. 11, p. 1150, doi. 10.1111/hiv.13525
- By:
- Publication type:
- Article
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade.
- Published in:
- HIV Medicine, 2022, v. 23, n. 1, p. 70, doi. 10.1111/hiv.13165
- By:
- Publication type:
- Article
'Emergency exit' of bone-marrow-resident CD34<sup>+</sup>DNAM-1<sup>bright</sup>CXCR4<sup>+</sup>-committed lymphoid precursors during chronic infection and inflammation.
- Published in:
- Nature Communications, 2015, v. 6, n. 10, p. 8109, doi. 10.1038/ncomms9109
- By:
- Publication type:
- Article
General Practitioners as partners for a shared management of chronic HIV infection: An insight into the perspectives of Italian People Living with HIV.
- Published in:
- PLoS ONE, 2021, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0254404
- By:
- Publication type:
- Article
Histopathologic and transmission electron microscopic findings in monkeypox cutaneous lesions.
- Published in:
- Infezioni in Medicina, 2024, v. 32, n. 1, p. 76, doi. 10.53854/liim-3201-10
- By:
- Publication type:
- Article
Monkeypox virus infection mimicking primary syphilis.
- Published in:
- Infezioni in Medicina, 2023, v. 31, n. 1, p. 113, doi. 10.53854/liim-3101-16
- By:
- Publication type:
- Article
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients With HIV/HCV Coinfection: Results of an Italian Compassionate Use Program.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, n. 5, p. 680, doi. 10.1093/cid/ciw846
- By:
- Publication type:
- Article
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection.
- Published in:
- 2016
- By:
- Publication type:
- Letter to the Editor
Off-label use of combined antiretroviral therapy, analysis of data collected by the Italian Register for HIV-1 infection in paediatrics in a large cohort of children.
- Published in:
- 2022
- By:
- Publication type:
- journal article
CD4+ T lymphocyte recovery in the modern antiretroviral therapy era: Toward a new threshold for defining immunological non-responders.
- Published in:
- Frontiers in Virology, 2023, p. 01, doi. 10.3389/fviro.2022.822153
- By:
- Publication type:
- Article
Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient—A Case Study.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 11, p. 1, doi. 10.1093/ofid/ofab217
- By:
- Publication type:
- Article
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 11, p. 1, doi. 10.1093/ofid/ofaa456
- By:
- Publication type:
- Article
Reply to: "Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19".
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 8, p. 1, doi. 10.1093/ofid/ofaa321
- By:
- Publication type:
- Article
Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study.
- Published in:
- Open Forum Infectious Diseases, 2018, v. 5, n. 6, p. N.PAG, doi. 10.1093/ofid/ofy113
- By:
- Publication type:
- Article
Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02447
- By:
- Publication type:
- Article
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project.
- Published in:
- Infection & Drug Resistance, 2018, v. 11, p. 615, doi. 10.2147/IDR.S152090
- By:
- Publication type:
- Article
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile.
- Published in:
- Drug Design, Development & Therapy, 2020, v. 14, p. 5515, doi. 10.2147/DDDT.S274307
- By:
- Publication type:
- Article
Predictors of retention in care in HIV-infected patients in a large hospital cohort in Italy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens.
- Published in:
- BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08191-2
- By:
- Publication type:
- Article
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda.
- Published in:
- BMC Infectious Diseases, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12879-023-08174-3
- By:
- Publication type:
- Article
The effect of formulary restriction in the use of antibiotics in an Italian hospital.
- Published in:
- European Journal of Clinical Pharmacology, 2001, v. 57, n. 6/7, p. 529, doi. 10.1007/s002280100338
- By:
- Publication type:
- Article
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS‐CoV‐2 infection.
- Published in:
- European Journal of Clinical Investigation, 2020, v. 50, n. 10, p. 1, doi. 10.1111/eci.13358
- By:
- Publication type:
- Article
Bloodstream infections in critically ill patients with COVID‐19.
- Published in:
- European Journal of Clinical Investigation, 2020, v. 50, n. 10, p. 1, doi. 10.1111/eci.13319
- By:
- Publication type:
- Article
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19.
- Published in:
- Journal of Geriatric Cardiology, 2021, v. 18, n. 5, p. 338, doi. 10.11909/j.issn.1671-5411.2021.05.004
- By:
- Publication type:
- Article
Durability of Second Antiretroviral Regimens in the Italian Cohort Naive Antiretrovirals Foundation Study and Factors Associated with Discontinuation.
- Published in:
- AIDS Patient Care & STDs, 2017, v. 31, n. 12, p. 487, doi. 10.1089/apc.2017.0140
- By:
- Publication type:
- Article
Management of the Medico-Legal Dispute of Healthcare-Related SARS-CoV-2 Infections: Evaluation Criteria and Case Study in a Large University Hospital in Northwest Italy from 2020 to 2021.
- Published in:
- International Journal of Environmental Research & Public Health, 2022, v. 19, n. 24, p. 16764, doi. 10.3390/ijerph192416764
- By:
- Publication type:
- Article
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA).
- Published in:
- AIDS Research & Therapy, 2019, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12981-019-0236-0
- By:
- Publication type:
- Article
Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunction.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 4, p. 1235, doi. 10.1007/s10238-022-00927-9
- By:
- Publication type:
- Article
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 1, p. 200
- By:
- Publication type:
- Article